Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate

This publication has 16 references indexed in Scilit:

• Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndrome
  Urology, 1994
• Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination Therapy
  Journal of Urology, 1993
• Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
  Journal of Clinical Oncology, 1993
• Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
  Cancer, 1993
• Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome
  Journal of Urology, 1993
• Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element
  Molecular Endocrinology, 1991
• Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
  Journal of Urology, 1991
• Comparative Experimental Study of the Serum Prostate Specific Antigen and Prostatic Acid Phosphatase in Serially Transplantable Human Prostatic Carcinoma Lines in Nude Mice
  Journal of Urology, 1988
• Therapy with progestational agents in advanced benign prostatic hypertrophy
  Published by American Medical Association (AMA) ,1969